Trials to begin on new Australian COVID-19 vaccine

SA researchers are behind the new DNA vaccine that targets the Omicron variant

A new COVID-19 vaccine developed in SA and administered with a needle-free device is to begin use in human trials.

Dr Makutiro Masavuli from the Basil Hetzel Institute researching the vaccine. Credit: University of Adelaide

The DNA vaccine targets the Omicron variant, whereas the Pfizer, AstraZeneca, Moderna and Novavax vaccines target the original strain of